Login / Signup

Response to 'Adverse cardiac outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors'.

Darryl P LeongChristopher HillisNazanin AghelGregory PondHsien Seow
Published in: Heart (British Cardiac Society) (2021)
Keyphrases
  • bone marrow
  • dendritic cells
  • left ventricular
  • acute myeloid leukemia
  • chronic myeloid leukemia
  • newly diagnosed
  • heart failure
  • adverse drug
  • insulin resistance